Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) SVP Kerr Holbrook sold 7,000 shares of the company's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $15.25, for a total value of $106,750.00. Following the completion of the sale, the senior vice president now owns 82,047 shares of the company's stock, valued at $1,251,216.75. This represents a 7.86 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Avanos Medical Trading Down 2.0 %
NYSE AVNS opened at $14.93 on Tuesday. The stock has a 50-day simple moving average of $16.00 and a 200 day simple moving average of $19.24. The company has a market capitalization of $686.87 million, a PE ratio of 43.91 and a beta of 1.17. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12. Avanos Medical, Inc. has a 12 month low of $14.40 and a 12 month high of $25.36.
Avanos Medical (NYSE:AVNS - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.43 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.03. The business had revenue of $179.60 million during the quarter, compared to the consensus estimate of $177.23 million. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. Research analysts forecast that Avanos Medical, Inc. will post 1.32 EPS for the current year.
Institutional Investors Weigh In On Avanos Medical
A number of institutional investors and hedge funds have recently added to or reduced their stakes in AVNS. Vanguard Group Inc. grew its stake in Avanos Medical by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 5,339,778 shares of the company's stock valued at $85,009,000 after acquiring an additional 19,476 shares during the period. T. Rowe Price Investment Management Inc. grew its stake in Avanos Medical by 27.2% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 3,011,312 shares of the company's stock valued at $47,941,000 after acquiring an additional 644,267 shares during the period. Brown Advisory Inc. grew its stake in Avanos Medical by 12.0% in the fourth quarter. Brown Advisory Inc. now owns 1,905,094 shares of the company's stock valued at $30,329,000 after acquiring an additional 204,218 shares during the period. William Blair Investment Management LLC grew its stake in Avanos Medical by 2.1% in the fourth quarter. William Blair Investment Management LLC now owns 1,406,210 shares of the company's stock valued at $22,387,000 after acquiring an additional 28,608 shares during the period. Finally, Paradice Investment Management LLC grew its stake in Avanos Medical by 2.5% in the fourth quarter. Paradice Investment Management LLC now owns 1,293,198 shares of the company's stock valued at $20,588,000 after acquiring an additional 30,949 shares during the period. Institutional investors own 95.17% of the company's stock.
Avanos Medical Company Profile
(
Get Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
